Clinical research professional with nearly 20 years of industry and academic clinical research experience in all aspects of clinical trials from feasibility to close out. Background experience in phase 1-4 studies with multiple indications including: neurological sciences, oncology, vaccines, gastrointestinal, cardiology, dermatology, pulmonary, diabetes/endocrine, and pediatric trials. Foundation continually built on deep-rooted quality, and team-first attitude. Emphasizes best practices at site and operational levels to strengthen efficiency and productivity while growing and maintaining established relationships – both internal and external. During my tenure as Site Director during the COVID-19 pandemic, our site grew from 10 FTE to 27 FTE team members. Our site in northeast Nebraska was also the first site to successfully enroll a patient into the first Phase 2, mRNA, SARS-COV-2 vaccine trial in the country.
